Cardioselective beta-blocker (β1 + β2 partial agonist)
Celiprolol hydrochloride
Brand names: Celectol
Adult dose
Dose: 200–400mg OD
Route: Oral
Frequency: OD
Clinical pearls
- NICE NG136 hypertension
- Specific role in vascular Ehlers-Danlos syndrome (RCP / EDS Society — reduces aortic events)
- ESC HT guidelines
Contraindications
- Severe asthma
- Decompensated HF
- Severe bradycardia / heart block
- Phaeochromocytoma without alpha-block
Side effects
- Fatigue
- Bradycardia
- Bronchospasm (less than non-selective)
- Hypotension
- Cold extremities
Interactions
- Verapamil/diltiazem
- Insulin/oral hypoglycaemics
Monitoring
- BP
- HR
- Symptoms
Reference: BNF; NICE NG136; RCP / EDS guidance; ESC HT; https://bnf.nice.org.uk/drugs/celiprolol-hydrochloride/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- MAGGIC Heart Failure Risk Score · Heart Failure
- Long QT Syndrome (Schwartz Score) · Channelopathy / Sudden Cardiac Death
- C-Peptide to Glucose Ratio · Diabetes Classification
- International Staging System (ISS) for Multiple Myeloma · Multiple Myeloma
- Revised ISS (R-ISS) for Multiple Myeloma · Haematological Malignancy
- International Staging System for Multiple Myeloma (ISS) · Oncology
Pathways
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines